InvestorsHub Logo
Followers 832
Posts 119832
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 11336

Wednesday, 07/09/2008 4:10:11 PM

Wednesday, July 09, 2008 4:10:11 PM

Post# of 19309
Clinical, Preclinical Goals for 2008-2009
(From Collins Stewart webcast, 9-Jul-2008)



The entry for HR (heparin resistance) protocol review is new.


Let’s talk biotech!
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.